Icagen, Inc. (ICGND) Return on Investment ROI from the third quarter of 2019 to third quarter of 2018 and for the year 2019, average high and low, overall ranking from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Icagen, Inc.  (ICGND)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Icagen,'s ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Icagen,'s ROI in the third quarter of 2019?
Icagen, Inc. recorded a cumulative net loss of $-14 million during 12 months ending in the third quarter of 2019, resulting in a negative return on investment (ROI) of -2041.6%.

Within the Healthcare sector 817 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2019 from 4585 to 4679.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Investment Change TTM -89.97 % -51.79 % -70.04 % -46.45 % 34.73 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -5 0 3 5 7
Return On Investment (TTM) - -290.17 % -372.52 % -303 % -158.14 %
ICGND's Overall Ranking # 4679 # 4585 # 4616 # 5010 # 4312
Seq. Investment Change TTM -81.3 % 16.63 % -24.77 % -38.9 % -10.07 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -14 -11 -12 -13 -11

ICGND Company Profile >> Back to ICGND Roi Comparisons >> See Annual ICGND Return On Investment



Return On Investment ICGND's Ranking
Within: No.
Industry # 37
Sector # 818
Overall # 4679

Return On Investment Statistics
High Average Low
154.94 %
-140.83 %
-1019.02 %
(Jun 30 2014)   (Jun 30 2013)







Financial Statements
Icagen,'s III. Quarter Investments $ -5 Millions ICGND's Balance sheet
Icagen,'s III. Quarter Income $ -6 Millions Quarterly ICGND's Income Statement
ICGND's Income by Division See ICGND's Income by Division


ICGND Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Investments in Millions 5 10 4 2 5
Y / Y Investment Growth -51.61 % 119.47 % 157.81 % -67.62 % -
Net Income in Millions -13 -6 -6 -9 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -278.74 % -63.21 % -124.96 % -507.79 % 0.94 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ICGND's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ICGND's Competitors
Subscribers only: Roi for Icagen,'s Suppliers
Subscribers only: Return On Investment for ICGND's Customers

Other Ratios
ICGND's Roa ICGND's Inventory Turnover Ratio ICGND's Growth Rates ICGND's Dividend Statistics
ICGND's Profitability Ratios ICGND's Asset Turnover Ratio ICGND's Dividend Growth
ICGND's Roe ICGND's Valuation Ratios ICGND's Financial Strength Ratios ICGND's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2019, within Healthcare Sector ROI

Date modified: 2026-09-08T15:09:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.